2m 2m 2m 2m 2m 2m 2m
ANAPTYSBIO (ANAB)
NASDAQ
$48.74+$0.005 (+0.01%)
Price as of Oct 26, 2026 5:39 PM EDT- $1.5BMarket Cap
- 38.95%1-Year Change
- BiotechnologyIndustry
ANAPTYSBIO (ANAB)
$48.74+$0.005 (+0.01%)
ANAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $48.73 | ||
Change | +$0.63 (+1.31%) | ||
Open | $48.19 | ||
High | $48.88 | ||
Low | $47.05 | ||
Previous Close | $48.10 | ||
Volume | 456,362 | ||
30-Day Average Volume | 578,780 | ||
1-Week Change | 4.55% | ||
1-Month Change | -4.02% | ||
1-Year Change | 38.95% | ||
3-Year Change | 177.51% | ||
5-Year Change | 70.68% | ||
Fundamentals | |||
Shares Outstanding | 29.9M | ||
Total Assets | $317.0M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | $0.00 | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 138 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue